CLMT icon

Calumet Specialty Products

16.04 USD
-2.36
12.83%
At close Jan 21, 4:00 PM EST
After hours
16.14
+0.10
0.62%
1 day
-12.83%
5 days
-27.45%
1 month
-19.23%
3 months
-24.16%
6 months
12.96%
Year to date
-26.39%
1 year
-0.06%
5 years
250.22%
10 years
-35.92%
 

About: Calumet Inc is a producer of specialty products, including base oils, specialty oils, solvents, esters, and waxes, as well as a variety of fuel and fuel-related products, including asphalt and heavy fuel oils. The company manufactures, formulates, and markets a variety of specialty branded products to customers in various consumer-facing and industrial markets.

Employees: 1,580

0
Funds holding %
of 6,823 funds
0
Analysts bullish %
of 3 analysts

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

156% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 16

137% more call options, than puts

Call options by funds: $80.3M | Put options by funds: $33.8M

47% more capital invested

Capital invested by funds: $389M [Q2] → $570M (+$181M) [Q3]

40% more funds holding in top 10

Funds holding in top 10: 5 [Q2] → 7 (+2) [Q3]

32% more funds holding

Funds holding: 68 [Q2] → 90 (+22) [Q3]

7.23% more ownership

Funds ownership: 30.15% [Q2] → 37.38% (+7.23%) [Q3]

11% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 19

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$26
62%
upside
Avg. target
$29
83%
upside
High target
$33
106%
upside

3 analyst ratings

positive
100%
neutral
0%
negative
0%
HC Wainwright & Co.
Amit Dayal
43% 1-year accuracy
47 / 110 met price target
106%upside
$33
Buy
Maintained
13 Jan 2025
TD Cowen
Jason Gabelman
39% 1-year accuracy
11 / 28 met price target
62%upside
$26
Buy
Maintained
11 Nov 2024
Wells Fargo
Roger Read
42% 1-year accuracy
44 / 104 met price target
81%upside
$29
Overweight
Maintained
21 Oct 2024

Financial journalist opinion

Based on 14 articles about CLMT published over the past 30 days

Positive
Zacks Investment Research
1 day ago
Calumet, Inc. (CLMT) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Calumet, Inc. (CLMT) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Calumet, Inc. (CLMT) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Positive
Seeking Alpha
6 days ago
The Real Calumet Financial Vision Just Stood Up
Calumet Specialty Products has transformed from difficult times to a valuable long-term investment, driven by superb execution, patience, and strategic asset management. Management announced a special analyst conference detailing an $800 million DOE loan at zero percent interest for four years, with significant debt reduction benefits. MRL production capacity will increase significantly through Phase I and Phase II expansions, promising substantial profit lifts and cost reductions.
The Real Calumet Financial Vision Just Stood Up
Neutral
PRNewsWire
6 days ago
Calumet Provides Update on Recent Financing Activity
INDIANAPOLIS , Jan. 15, 2025 /PRNewswire/ -- Calumet, Inc. (NASDAQ: CLMT) (the "Company," "Calumet," "we," "our" or "us") provided an update on its recent financing activity, including the pricing by its wholly owned subsidiaries, Calumet Specialty Products Partners, L.P. (the "Partnership") and Calumet Finance Corp., of their private placement of $100 million in aggregate principal amount of 9.75% Senior Notes due 2028 (the "Notes Offering") and registration its $65 million at-the-market equity program (the "ATM Program").
Calumet Provides Update on Recent Financing Activity
Neutral
PRNewsWire
6 days ago
Calumet Announces Pricing of $100 Million Private Placement of 9.75% Senior Notes due 2028
INDIANAPOLIS , Jan. 14, 2025 /PRNewswire/ -- Calumet, Inc. (NASDAQ: CLMT) (the "Company" or "Calumet") today announced that its wholly owned subsidiaries, Calumet Specialty Products Partners, L.P. (the "Partnership") and Calumet Finance Corp. (together with the Partnership, the "Issuers"), priced their private placement (the "Offering") under Rule 144A and Regulation S under the Securities Act of 1933, as amended (the "Securities Act"), of $100 million in aggregate principal amount of 9.75% Senior Notes due 2028 (the "New Notes").
Calumet Announces Pricing of $100 Million Private Placement of 9.75% Senior Notes due 2028
Neutral
PRNewsWire
1 week ago
Calumet Announces $100 Million Private Placement of 9.75% Senior Notes due 2028
INDIANAPOLIS , Jan. 14, 2025 /PRNewswire/ -- Calumet, Inc. (NASDAQ: CLMT) (the "Company" or "Calumet") today announced that, subject to market conditions, its wholly owned subsidiaries, Calumet Specialty Products Partners, L.P. (the "Partnership") and Calumet Finance Corp. (together with the Partnership, the "Issuers"), intend to offer (the "Offering") for sale to eligible purchasers in a private placement under Rule 144A and Regulation S under the Securities Act of 1933, as amended (the "Securities Act"), $100 million in aggregate principal amount of 9.75% Senior Notes due 2028 (the "New Notes").
Calumet Announces $100 Million Private Placement of 9.75% Senior Notes due 2028
Neutral
PRNewsWire
1 week ago
Calumet Announces $65 Million At-the-Market Equity Offering Program
INDIANAPOLIS , Jan. 14, 2025 /PRNewswire/ -- Calumet, Inc. (NASDAQ: CLMT) (the "Company" or "Calumet") today announced that the Company has filed a prospectus supplement with the U.S. Securities and Exchange Commission (the "SEC") establishing an at-the-market equity offering program (the "ATM Program") under which it may issue and sell, from time to time, shares of its common stock having an aggregate gross sales price of up to $65 million (the "Offered Shares"). Calumet intends to use the net proceeds from the ATM Program for general corporate purposes, which may include, among other things, repayment of indebtedness, working capital and capital expenditures.
Calumet Announces $65 Million At-the-Market Equity Offering Program
Neutral
PRNewsWire
1 week ago
Calumet Provides Preliminary Fourth Quarter 2024 Selected Financial Results
INDIANAPOLIS , Jan. 14, 2025 /PRNewswire/ -- Calumet, Inc. (NASDAQ: CLMT) (the "Company," "Calumet," "we," "our" or "us") announced today preliminary selected financial results for the fourth quarter ended December 31, 2024. Based on preliminary data, the Company currently expects to report a net loss between $54 million and $24 million and Adjusted EBITDA between $45 million and $60 million for the fourth quarter 2024.
Calumet Provides Preliminary Fourth Quarter 2024 Selected Financial Results
Positive
Zacks Investment Research
1 week ago
Calumet Closes $1.44B DOE Loan for Renewable Fuel Expansion
CLMT subsidiary Montana Renewables advances as a global leader in Sustainable Aviation Fuel, capable of producing 300M gallons per year with the DOE loan.
Calumet Closes $1.44B DOE Loan for Renewable Fuel Expansion
Neutral
Seeking Alpha
1 week ago
Calumet, Inc. (CLMT) Analyst Update Call (Transcript)
Calumet, Inc. (NASDAQ:CLMT ) Analyst Update Call January 13, 2025 9:00 AM ET Company Participants John Kompa - Director, IR Todd Borgmann - Chief Executive Officer Bruce Fleming - EVP, Montana Renewables and Corporate Development Conference Call Participants Roger Read - Wells Fargo Neil Mehta - Goldman Sachs Saumya Jain - UBS Jason Gabelman - TD Cowen Amit Dayal - H.C. Wainwright Operator Good morning, and welcome to the Calumet Inc. Analyst update.
Calumet, Inc. (CLMT) Analyst Update Call (Transcript)
Neutral
Seeking Alpha
1 week ago
Update On Calumet, My Largest Investment
Update On Calumet, My Largest Investment
Update On Calumet, My Largest Investment
Charts implemented using Lightweight Charts™